Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trial is a research paper published in EuroIntervention (2024). On theSindex it has a DataRank of 0.513. It has been cited 8 times, with 8 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.183
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 8 citers.
NHLBI NIH HHS
Grant: U01 HL105907
NCATS NIH HHS
Grant: UL1 TR002243
NHLBI NIH HHS
Grant: U01 HL105462
NHLBI NIH HHS
Grant: U01 HL105565
NHLBI NIH HHS
Grant: U01 HL105561
NCATS NIH HHS
Grant: UL1 TR001445
NHLBI NIH HHS
Grant: T32 HL079896
National Institutes of Health
Grant: 5U01HL105565-03
The ISCHEMIA Trial - EQOL
National Institutes of Health
Grant: 5UL1TR002243-05
Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 4U01HL105462-05
The ISCHEMIA Trial - SDCC
National Institutes of Health
Grant: 3UL1TR001445-03S1
Clinical and Translational Science Award
National Institutes of Health
Grant: 4U01HL105561-05
The ISCHEMIA Trial - IICC
National Institutes of Health
Grant: 2T32HL079896-06A1
Integrated Biostatistical Training for CVD Research
National Institutes of Health
Grant: 3U01HL105907-02S1
The Ischemia Trial - CCC
FWCI
3.74
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals